Both in Surgical Instruments
Embecta vs Carlsmed
Over the past year EMBC returned −54.7% and CARL returned +17.8%; their daily moves had a correlation of 0.14.
EMBC −54.7% CARL +17.8%Growth of $1, one year, split-adjusted
| Metric | EMBC | CARL |
|---|---|---|
| Price | $6.08 | $14.40 |
| Market cap | $344.5M | $393.2M |
| Today | −1.78% | −4.13% |
| 1 month | +3.4% | −5.9% |
| 6 months | +55.9% | +61.4% |
| Year to date | −48.8% | +16.6% |
| 1 year | −54.4% | +11.7% |
| Revenue growth (YoY) | −8.1% | — |
| Gross margin | 56.4% | 76.8% |
| Net margin | 7.8% | −55.5% |
| P/E (TTM) | 3.9× | — |
| Price / sales | 0.3× | 6.2× |
| Net cash | -$1.27B | $73.8M |
| Dividend yield | 0.66% | — |
| Volatility (60d) | 51.5% | 47.7% |
| Short % of float | 10.5% | 11.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).